Sanofi Showcases Rare Disease Pipeline Innovations at ISTH
Sanofi Highlights Robust Pipeline of Innovations in Rare Blood Disorders at ISTH 2025 Sanofi is poised to take center stage at the 33rd Congress of the International Society on Thrombosis…
EU Approves Fixed-Duration Calquence Regimens for 1st-Line CLL
AstraZeneca’s Fixed-Duration Calquence Regimen Gains EU Approval for First-Line Treatment of Chronic Lymphocytic Leukaemia AstraZeneca has received European Union (EU) approval for a fixed-duration combination therapy using its Bruton’s tyrosine…
Immunization at Every Stage of Life: A Key to Lifelong Health
A Life-Course Approach to Immunization: Prioritizing Vaccination at Every Age to Unlock the Full Potential of Lifelong Health In a striking demographic milestone, the global population is undergoing a historic…
WHO Urges Protection for Gaza’s Nasser and Al-Amal Hospitals
WHO Sounds Alarm on Imminent Collapse of Gaza Health System as Nasser and Al-Amal Hospitals Face Shutdown The World Health Organization (WHO) has issued an urgent warning about the imminent…
Grifols Names Anne-Catherine Berner as New Board Chair
Anne-Catherine Berner Appointed as New Chair of Grifols: A Strategic Move Toward Long-Term Value Creation and Governance Excellence Grifols a global leader in the development of plasma-derived therapies and diagnostic…
Finerenone and SGLT2 Inhibitor Combo Shows Promise in CKD with Type 2 Diabetes
Bayer’s CONFIDENCE Study Demonstrates Promising Results for Simultaneous Use of Finerenone and Empagliflozin in Managing Chronic Kidney Disease in Type 2 Diabetes Bayer has announced compelling new clinical findings from…
Zoetis Highlights Environmental and Social Impact in 2024 Update
Zoetis Unveils 2024 Sustainability Progress Report, Showcasing Global Commitments to Communities, Animal Health, and the Planet Zoetis, a global leader in animal health, has released its 2024 Sustainability Progress Update,…
Sanofi Launches 2025 Global Stock Plan for Employees
Sanofi Unveils 2025 Global Employee Shareholding Plan, Reinforcing Long-Term Workforce Commitment Sanofi has officially launched Action 2025, the latest installment of its long-running global employee shareholder program. Opening on June…
Vividion and Bayer Advance Oncology Pipeline with WRN Inhibitor
Vividion and Bayer Expand Oncology Pipeline with Exclusive Rights to Clinical-Stage WRN Inhibitor VVD-214 Vividion Therapeutics,a clinical-stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, has announced a significant…
CPR Training Turns Heroic: Walgreens Manager Revives Daughter in Emergency
CPR Training Turns Walgreens Manager into a Hero Dad: How Quick Thinking Saved His Daughter’s Life Adyn Romahn was enjoying a quiet moment at home in Great Bend, Kansas, watching…
ODA Cuts Deepen the Neglect of Tropical Diseases
Neglected Again: ODA Cuts Threaten Global Progress on Tropical Diseases Neglected tropical diseases (NTDs) continue to plague over a billion people around the world, predominantly affecting vulnerable populations in low-resource…
Primary Health Care on the Rise Worldwide: Now Is the Time to Stand Together
Global Drive for Primary Health Care Gains Ground at World Health Assembly: A Unified Call to Action In a powerful demonstration of international unity and purpose, global health leaders convened…